Full-Time
Field Reimbursement Manager
Confirmed live in the last 24 hours
Develops next-generation immuno-oncology therapies
Compensation Overview
$165,000 - $190,000Annually
Mid, Senior
California, USA + 3 more
- 5+ years of commercial experience in the pharmaceutical or biotech industry.
- 3+ years of experience in healthcare coverage, coding and/or reimbursement.
- Direct experience with Buy and Bill products, Medicare Part B and Miscellaneous J-Codes required.
- Oncology experience strongly preferred.
- Bachelor's degree from a four-year college or university.
- Partner with internal and external stakeholders to identify, anticipate and address patient and practice reimbursement issues
- Collaborate with Field Sales to identify facilities and practices that need reimbursement education and support regarding Coherus products.
- Provide insights and updates regarding product and support service integration at accounts.
- Educate facility staff on policies related to product acquisition, inventory management, and all payer polices related to support full integration of product into the practice workflow.
- Provide coverage, coding, and reimbursement information to key staff members (i.e., practice administrators, reimbursement staff, and providers) in order to appropriately support patient access.
- Collaborate with field facing “One Team” to compliantly share insights into customer needs, potential barriers, and payer issues/opportunities for access at practices.
- Communicate and explain payer policy updates or system changes that impact access.
- Proactively communicate Coherus COMPLETE™ so that office staff is fluent in how to use patient access programs and services.
- Address questions associated with patient coverage, access, and reimbursement from accounts in collaboration and coordination with patient services as directed by policy and procedure.
- Conduct frequent claim reviews with practices to ensure appropriate reimbursement of Coherus products.
- Maintain a deep understanding of Coherus policies and requirements and perform the role in a compliant manner consistent with company guidance.
- Keep abreast of customer and market access industry trends.
With an emphasis on immuno-oncology and cutting-edge therapies, this company stands out in the biotechnology industry for its dedicated approach to cancer treatment and improving patient outcomes. The development and FDA-approval of cutting-edge treatments like toripalimab-tpzi underscore its role as a leader in oncology research. Its focus on next-generation therapies and a differentiated PD-1 inhibitor highlights the company's commitment to both innovation and tangible results in healthcare.
Company Stage
IPO
Total Funding
$1.2B
Headquarters
Redwood City, California
Founded
2010
6 month growth
↓ -6%1 year growth
↓ -6%2 year growth
↓ -6%Benefits
Competitive base salary
Target bonus based on performance
stock options
Medical, dental, & vision coverage
PTO
401(k) plan
FSA